http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#Head http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#assertion http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#provenance http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#pubinfo http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#assertion http://purl.obolibrary.org/obo/DOID_1067 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1067 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00654 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association http://www.w3.org/2000/01/rdf-schema#label latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension latanoprost ophthalmic solution is a prostaglandin f2a analogue indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension 1 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00654 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#provenance http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#pubinfo http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#sig http://purl.org/nanopub/x/hasSignature AqrlvN/jp/czDDj3Tfu83DrtZpXZMwWgUwY3Y7wPSjhZ6gNskLp656Gnyr7mraBCUTcajv36Iv6Qg327puOCtG2xjCB1VDAj1umRNGp0GkcF2xDZk5U4DHGx9JiiGLEYkhO0WWlHEQ3E57T0V5WRhLEKCE1FbWdWwQDffzdw9/8= http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://purl.org/dc/terms/created 2021-07-03T14:26:10.870+02:00 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAgeZNu4CQBxwriHdpASBoltaHVqYd7N9-FNFfitcvdYs https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs